Skip to main content
HE

heXem bio

Los Angeles, United States
Last funding
$10.4M
SeedSep 2026

HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.

About heXem bio

How much funding has heXem bio raised?

heXem bio has raised $10.4M in total funding. The most recent round was Seed. The last funding was announced in September 2026.

Who are heXem bio's investors?

heXem bio's investors include Alumni Ventures, Gaingels, Draper Associates, Seraphim Space, Boost VC.

Where is heXem bio headquartered?

heXem bio is headquartered in Los Angeles, United States.

What does heXem bio do?

HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.

What stage is heXem bio at?

heXem bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"heXem bio — Funding & Investors." VCBacked, September 15, 2026, https://www.vcbacked.co/company/hexem-bio. Accessed November 15, 2026.
APA
VCBacked. (2026). heXem bio — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/hexem-bio
Wikipedia (cite web)
{{cite web |title=heXem bio — Funding & Investors |url=https://www.vcbacked.co/company/hexem-bio |website=VCBacked |access-date=November 15, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at heXem bio? Request a listing update

Founder contacts
m***@hexemb.io
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →